Abstract:Purpose: Osteosarcoma is a malignant musculoskeletal tumor with early metastasis and a poor prognosis, especially in adolescents. Ganoderma lucidum (Leyss. Ex Fr.) Karst (G. lucidum), a traditional East Asian medicine, has been reported to play a critical role in antitumor and immunomodulatory activity. The aim of this study was to investigate the effects and molecular mechanisms of water extract of sporoderm-broken spores of G. lucidum (BSGWE) on osteosarcoma PD-L1 (programmed cell death-ligand 1) transcriptional regulation, efficacy enhancement, and side effect remission. Methods: The antitumor effects on cell proliferation of BSGWE in osteosarcoma cells were detected by apoptosis flow cytometry, and the migration ability of HOS and K7M2 cells were evaluated by cell scratch assay. Potential signaling regulation of PD-Ll was detected by western blotting. To confirm the signaling pathway of BSGWE-related PD-L1 downregulation, a pho-STAT3 turnover experiment was carried out. Colivelin was administered as a pho-STAT3 activator to rescue the BSGWE-induced PD-L1 inhibition. To further study in vivo signaling, in a Balb/c osteosarcoma allograft model, tumor volume was measured using an in vivo bioluminescence imaging system. The body weight curve and tumor volume curve were analyzed to reveal the remission effects of BSGWE on PD-L1 antibody-related body weight loss and its immunomodulatory effects on the osteosarcoma and spleen. The PD-L1 expression level and expression of related transcription-factor pho-STAT3 in tumor cells and spleens were assessed by IHC analysis. Results: BSGWE suppressed the proliferation and migration of osteosarcoma cells in vitro via induction of apoptosis. In addition, BSGWE downregulated PD-L1 expression and related STAT3 (signal transducers and activators of transcription) phosphorylation levels in a dose-dependent manner. Western blotting and qRT-PCR assay revealed that BSGWE downregulated PD-L1 expression by inhibiting STAT3 phosphorylation. A turnover experiment showed that colivelin administration could rescue PD-L1 inhibition via pho-STAT3 activation. BSGWE not only downregulated PD-L1 expression via the STAT3 pathway in an allograft Balb/c mouse model, but also relieved complications including weight loss and spleen atrophy in a mouse monoclonal antibody therapy model on the basis of its traditional advantages in immune enhancement. Conclusion: BSGWE downregulated PD-L1 expression via pho-STAT3 inhibition of protein and RNA levels. BSGWE enhanced PD-L1 antibody efficacy via phosphorylated STAT3 downregulation in vitro and in vivo. BSGWE also relieved complications of weight loss and spleen atrophy in a murine allograft osteosarcoma immune checkpoint blockade therapy model.

Enhancement of cyclophosphamide-induced antitumor effect by a novel polysaccharide from Ganoderma atrum in sarcoma 180-bearing mice

Ganoderma atrum polysaccharide induces anti-tumor activity via the mitochondrial apoptotic pathway related to activation of host immune response

Chemoprotective effects of Ganoderma atrum polysaccharide in cyclophosphamide-induced mice

Molecular Mechanism Underlying Chemoprotective Effects of Ganoderma Atrum Polysaccharide in Cyclophosphamide-Induced Immunosuppressed Mice

A Polysaccharide from Ganoderma Atrum Inhibits Tumor Growth by Induction of Apoptosis and Activation of Immune Response in CT26-Bearing Mice

Immunomodulatory effect of Ganoderma atrum polysaccharide on CT26 tumor-bearing mice.

Ganoderma Atrum Polysaccharide Evokes Antitumor Activity Via Camp-Pka Mediated Apoptotic Pathway and Down-Regulation of Ca(2+)/PKC Signal Pathway.

Polysaccharide from Ganoderma Atrum Evokes Antitumor Activity Via Toll-like Receptor 4-Mediated NF-κB and Mitogen-Activated Protein Kinase Signaling Pathways.

Ganoderma atrum polysaccharide ameliorates ROS generation and apoptosis in spleen and thymus of immunosuppressed mice

Water Extract of Sporoderm-Broken Spores of Ganoderma Lucidum Enhanced Pd-L1 Antibody Efficiency Through Downregulation and Relieved Complications of Pd-L1 Monoclonal Antibody.

A Novel Polysaccharide from Ganoderma Atrum Exerts Antitumor Activity by Activating Mitochondria-Mediated Apoptotic Pathway and Boosting the Immune System

Ganoderma atrum polysaccharide modulates TNF-α secretion and mRNA expression in macrophages of S-180 tumor-bearing mice

Combined Use of Insoluble Beta-Glucan from the Cell Wall of Candida Albicans and Cyclophosphamide: Validation in S180 Tumor-Bearing Mice

Sulfated Modification Enhances the Immunomodulatory Effect of Cyclocarya Paliurus Polysaccharide on Cyclophosphamide-Induced Immunosuppressed Mice Through MyD88-dependent MAPK/NF-κB and PI3K-Akt Signaling Pathways.

Enhancement of antitumor activities in sulfated and carboxymethylated polysaccharides of Ganoderma lucidum.

polysaccharides enhance antitumor immune responses by downregulating the differentiation of myeloid-derived suppressor cells and tumor-associated macrophages

Synergistic Effect of Tremella Fuciformis Spores Polysaccharides on Tumor Bearing Mice Treated by Cyclophosphamide

Growth-inhibition of S180 Residual-Tumor by Combination of Cyclophosphamide and Chitosan Oligosaccharides in Vivo

Effect of Polysaccharides from Ganoderma atrum on Spleen Lymphocyte Proliferation and Induction of Cytokine in Mice

Effect of 20 (S)-ginsenoside Rg3 combined with cytotoxic agents on sarcoma 180 of mice

Ganoderma atrum polysaccharide ameliorates intestinal mucosal dysfunction associated with autophagy in immunosuppressed mice